PROVIDER PROFILE · NPI 1518935188

Lisa KatesM.D.

DermatologyCrofton, MDI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

2,616

Unique beneficiaries

—

Total services

7,040

Distinct HCPCS

Medicare payment

$344K

Peer benchmark

Total Medicare services vs. 262 Dermatology providers in MD — top quintile (cohort median 2,654).

PRESCRIBING · PART D · 2024

Total Rx claims

330

Beneficiaries

—

Total drug cost

$115K

Distinct drugs

Brand share

8.5%

Top prescribed drugs

Mupirocin70 claims

Ketoconazole59 claims

Clobetasol Propionate53 claims

Triamcinolone Acetonide35 claims

Efinaconazole15 claims

QUALITY · MIPS · 2024

Final MIPS score

90.6

Quality

81.2

Cost

0.0

Improvement activities

40.0

Promoting interop.

0.0

Payment adjustment

0.66%

Individual

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$796

Payment records

By payment type

Food and Beverage$796

Top paying entities

Food and Beverage$796

REFERRAL NETWORK

Where Lisa Kates's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
LUMINIS HEALTH ANNE ARUNDEL MEDICAL CENTER, INC.	28	49
Quest Diagnostics Incorporated Md Clinical Laboratory · Baltimore, MD	23	37
Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ	22	39
Aizenhawar Marrogi Pathology · Mclean, VA	18	30
SCHULTZ, HOWARD	17	26

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history